Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators.
Publication
, Journal Article
Ballard, CAP; Goff, KM; Patel, MP; Walsh, KM; Monje, M; Ostrom, QT
Published in: Neuro Oncol
December 8, 2025
Duke Scholars
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
December 8, 2025
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ballard, C. A. P., Goff, K. M., Patel, M. P., Walsh, K. M., Monje, M., & Ostrom, Q. T. (2025). Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators. Neuro Oncol. https://doi.org/10.1093/neuonc/noaf280
Ballard, Christine Ann Pittman, Kevin M. Goff, Mallika P. Patel, Kyle M. Walsh, Michelle Monje, and Quinn T. Ostrom. “Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators.” Neuro Oncol, December 8, 2025. https://doi.org/10.1093/neuonc/noaf280.
Ballard CAP, Goff KM, Patel MP, Walsh KM, Monje M, Ostrom QT. Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators. Neuro Oncol. 2025 Dec 8;
Ballard, Christine Ann Pittman, et al. “Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators.” Neuro Oncol, Dec. 2025. Pubmed, doi:10.1093/neuonc/noaf280.
Ballard CAP, Goff KM, Patel MP, Walsh KM, Monje M, Ostrom QT. Gabapentin repurposing for glioblastoma therapy: Real-world data analyses augmented by use of active comparators. Neuro Oncol. 2025 Dec 8;
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
December 8, 2025
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences